VivaVision and Everads Collaborate to Develop Durable and Effective Therapies for Retinal Diseases
2023-01-11 11:30:59
TEL AVIV, Israel and SHANGHAI, Jan. 6, 2023 -- VivaVision, a pharmaceutical company developing innovative therapies for ocular diseases, and Everads Therapy, a biotech company developing optimized retinal therapies by leveraging its novel suprachoroidal
View details